Product Information
SIMVASTATIN 40 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0538 per EA under NDC 69367037610. Its NADAC has been published 66 times since Jul 2, 2025.
FDA first approved this application on Nov 27, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367037610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA211394FDA Approved
11/27/2024
TE Code
AB
On Market Since
4/14/2025
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 40 MG TABLET has been published 66 times since Jul 2, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0538 per EA |
|---|---|
| All-time high | $0.0547 (Apr 15, 2026) |
| All-time low | $0.0519 (Oct 22, 2025) |
| 52-week high | $0.0547 |
| 52-week low | $0.0519 |
| Median price | $0.0539 |
| Average price | $0.0539 |
| Largest weekly change | -2.5% (Oct 22, 2025) |
| Weeks tracked | 66 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0538 per EA (NDC 69367037610), effective Sep 30, 2026.
How has the price of SIMVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 66 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?
Since Jul 2, 2025, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0519 (Oct 22, 2025) to a high of $0.0547 (Apr 15, 2026), with a median of $0.0539 per EA.
Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 40 MG TABLET, is $0.0410 per EA — about 24% below SIMVASTATIN 40 MG TABLET.
Who manufactures SIMVASTATIN 40 MG TABLET?
SIMVASTATIN 40 MG TABLET (NDC 69367037610) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.